Condition

Refractory Anemia

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions9

Lead sponsors shown2

Clinical trials

2 shown

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersNCT04083170 · 2022-10-06

TERMINATED

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01

COMPLETED

Common interventions

CyclophosphamideDRUG1deferasiroxDRUG1DilanubicelBIOLOGICAL1enzyme-linked immunosorbent assayOTHER1FludarabineDRUG1laboratory biomarker analysisOTHER1ThiotepaDRUG1Total-Body IrradiationRADIATION1Umbilical Cord Blood TransplantationPROCEDURE1

Leading sponsors

Fred Hutchinson Cancer Center1Wake Forest University Health Sciences1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.